 Sosei Group Corporation the Company; TSE: 4565 notes that its strategic alliance partner Novartis SWX: NOVN announced that the European Medicines Agencys EMA Committee for Medicinal Products for Human Use CHMP recommended the approval in the European Union of Enerzair Breezhaler 